Audrea H Szabatura

发表

S. Bartel, Audrea H Szabatura, C. Moore, 2017 .

High performance teamwork training and systems redesign in outpatient oncology

E. Winer, M. Salisbury, H. Burstein, 2013, BMJ quality & safety.

Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant

Audrea H Szabatura, S. Nesbit, J. E. Howell, 2008, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

NCCN Task Force Report: Specialty Pharmacy.

J. Hinkel, Philip E. Johnson, A. Seung, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

A perspective on dose banding.

Audrea H Szabatura, Jake B. Guinto, 2013, The Journal of the National Comprehensive Cancer Network.

An assessment of risk factors associated with ifosfamide-induced encephalopathy in a large academic cancer center

D. Neuberg, D. Fisher, Frank Cirrone, 2015, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

NCCN Task Force Report: Specialty Pharmacy.

J. Hinkel, Philip E. Johnson, A. Seung, 2010, The Journal of the National Comprehensive Cancer Network.